These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 12202407)

  • 21. Metformin and troglitazone in the treatment of female infertility associated with polycystic ovarian syndrome.
    Sangraula H; Paudel KR; Sharma M
    JNMA J Nepal Med Assoc; 2009; 48(176):335-9. PubMed ID: 21105563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of polycystic ovary syndrome with insulin-lowering agents.
    Glueck CJ; Streicher P; Wang P
    Expert Opin Pharmacother; 2002 Aug; 3(8):1177-89. PubMed ID: 12150695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin in polycystic ovary syndrome.
    Diamanti-Kandarakis E; Economou F; Palimeri S; Christakou C
    Ann N Y Acad Sci; 2010 Sep; 1205():192-8. PubMed ID: 20840272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin for polycystic ovary syndrome.
    Milewicz A
    Endokrynol Pol; 2013; 64(5):409-14. PubMed ID: 24186599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of lean polycystic ovary syndrome with early stage of type 1 diabetes successfully treated with metformin.
    Shigiyama F; Kumashiro N; Rikitake T; Usui S; Saegusa M; Kitamura M; Uchino H; Hirose T
    Endocr J; 2016; 63(2):193-8. PubMed ID: 26765270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study.
    Glueck CJ; Phillips H; Cameron D; Sieve-Smith L; Wang P
    Fertil Steril; 2001 Jan; 75(1):46-52. PubMed ID: 11163815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polycystic ovarian syndrome--prognosis and outcomes.
    Hart R; Norman R
    Best Pract Res Clin Obstet Gynaecol; 2006 Oct; 20(5):751-78. PubMed ID: 16766228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adolescents with Classical Polycystic Ovary Syndrome Have Alterations in the Surrogate Markers of Cardiovascular Disease but Not in the Endothelial Function. The Possible Benefits of Metformin.
    Fruzzetti F; Ghiadoni L; Virdis A; De Negri F; Perini D; Bucci F; Giannarelli C; Gadducci A; Taddei S
    J Pediatr Adolesc Gynecol; 2016 Oct; 29(5):489-495. PubMed ID: 27018756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
    Sahin Y; Unluhizarci K; Yilmazsoy A; Yikilmaz A; Aygen E; Kelestimur F
    Clin Endocrinol (Oxf); 2007 Dec; 67(6):904-8. PubMed ID: 17666089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study.
    Morin-Papunen L; Vauhkonen I; Koivunen R; Ruokonen A; Martikainen H; Tapanainen JS
    J Clin Endocrinol Metab; 2003 Jan; 88(1):148-56. PubMed ID: 12519844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome.
    Lord JM; Flight IH; Norman RJ
    Cochrane Database Syst Rev; 2003; (3):CD003053. PubMed ID: 12917943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Molecular action of insulin-sensitizing agents].
    Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
    Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin in obstetric and gynecologic practice: a review.
    McCarthy EA; Walker SP; McLachlan K; Boyle J; Permezel M
    Obstet Gynecol Surv; 2004 Feb; 59(2):118-27. PubMed ID: 14752300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should physicians prescribe metformin to women with polycystic ovary syndrome PCOS?
    Duranteau L; Lefevre P; Jeandidier N; Simon T; Christin-Maitre S
    Ann Endocrinol (Paris); 2010 Feb; 71(1):25-7. PubMed ID: 20079483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Metformin therapy in polycystic ovary syndrome].
    Jakimiuk AJ
    Ginekol Pol; 2008 Jan; 79(1):8-11. PubMed ID: 18510043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response.
    Palomba S; Falbo A; Russo T; Orio F; Tolino A; Zullo F
    Hum Reprod; 2010 Apr; 25(4):1005-13. PubMed ID: 20106839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polycystic ovary syndrome (PCOS) and the accompanying disorders of glucose homeostasis among girls at the time of puberty.
    Otto-Buczkowska E; Grzyb K; Jainta N
    Pediatr Endocrinol Diabetes Metab; 2018; 24(1):40-44. PubMed ID: 30083660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-sensitisers in the treatment of polycystic ovary syndrome.
    Teede HJ; Meyer C; Norman RJ
    Expert Opin Pharmacother; 2005 Nov; 6(14):2419-27. PubMed ID: 16259573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of metformin in polycystic ovary syndrome.
    De Sloover Koch Y; Ernst ME
    Ann Pharmacother; 2001 Dec; 35(12):1644-7. PubMed ID: 11793635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The guidelines issued by the European Society for Human Reproduction and Embryology and the American Society for Reproductive Medicine regarding the induction of ovulation with metformin in patients with the polycystic ovary syndrome potentially require reconsideration.
    Panidis D; Tziomalos K; Papadakis E; Kandaraki EA; Katsikis I
    Hormones (Athens); 2013; 12(2):192-200. PubMed ID: 23933688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.